Rely on the most comprehensive, up-to-date legal content designed and curated by lawyers for lawyers
Work faster and smarter to improve your drafting productivity without increasing risk
Accelerate the creation and use of high quality and trusted legal documents and forms
Streamline how you manage your legal business with proven tools and processes
Manage risk and compliance in your organisation to reduce your risk profile
Stay up to date and informed with insights from our trusted experts, news and information sources
Access the best content in the industry, effortlessly — confident that your news is trustworthy and up to date.
Find up-to-date guidance on points of law and then easily pull up sources to support your advice with Lexis PSL
With over 30 practice areas, we have all bases covered. Find out how we can help
Our trusted tax intelligence solutions, highly-regarded exam training and education materials help guide and tutor Tax professionals
Regulatory, business information and analytics solutions that help professionals make better decisions
A leading provider of software platforms for professional services firms
In-depth analysis, commentary and practical information to help you protect your business
LexisNexis Blogs shed light on topics affecting the legal profession and the issues you're facing
Legal professionals trust us to help navigate change. Find out how we help ensure they exceed expectations
Lex Chat is a LexisNexis current affairs podcast sharing insights on topics for the legal profession
Discuss the latest legal developments, ask questions, and share best practice with other LexisPSL subscribers
often say they wish they had more input into how to run their businesses from people who are not lawyers, or former lawyers. This is because they feel they benefit from learning how other businesses do things. One such example of a company with a
lesson attached is that of the troubled North American pharmaceutical company Valeant.
Fundamentally, Valeant and its current crisis, which is now filling the front pages of the business press on both sides of the Atlantic, is a story of losing sight of the key purpose of the company, that is to say losing sight of making the best possible
product for its customers.
Valeant became a global pharma company in the 1990s through a series of combinations with other large pharma businesses. Scale helped it to compete with rivals and its greater revenues also helped to fund the vital research and development (R&D) of
new and improved products that would make their customers’ lives better. As one can imagine, developing new drugs to sell to customers was the “base of the pyramid” in terms of running the business. No new drugs to sell = no future
But, then some new managers at Valeant had a bright idea, or so they thought: there is no need to develop new products, we will slash research spending and use the extra cash to buy up other pharma companies and the products they already own.
The argument went: why innovate, why spend time nurturing our talent, why invest our own money on building something when we can just build a conglomerate based on other people’s past efforts?
The result would be a much larger business with far lower research costs. It also practised the art of price gouging on its key drugs. Why? Just because it could as it believed it had a monopoly on those kinds of products. And it moved its HQ to Canada
primarily to lower the tax it paid in the US, not for any customer-related purpose. A genius strategy some believed. And its share price rose rapidly as belief in the strategy spread through the market (see Table 1).
Access this article and thousands of others like it free by subscribing to our blog.
Read full article
Already a subscriber? Login
Richard helps law firms with important strategic decisions. He
advises on areas such as merger, practice development and geographical
expansion. He also provides assistance to law firms in relation to
organisational and operational issues.
Richard has spent over 16 years working in the legal sector focused
on the UK and global legal markets. He previously worked at Jomati as a
strategy consultant and authored the Jomati Report series between 2009
Prior to that, Richard worked at US-based, Hildebrandt International,
and also held senior, legal sector editorial roles in London and Paris.
0330 161 1234